Synonyms: Aerosporin®
polymyxin B is an approved drug (FDA (1964, no prior history available))
Compound class:
Peptide
Comment: Polymyxin B is a mixture of the polypeptides polymyxins B1 and B2, both obtained from Bacillus polymyxa strains. It is an antibacterial compound that demonstrates bactericidal action against almost all Gram-negative bacilli except the Proteus group.
|
|
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
Targets where the ligand is described in the comment field | |
Target | Comment |
Peptide transporter 2 | Although most di/tripeptides can bind PEPT2, not all of them are substrates. The uptake depends on the structural features (charge, hydrophobicity, size, side chain flexibility, etc.) of the di/tripeptide. Like PEPT1, PEPT2 interacts with dipeptides and drugs including D-Phe-Ala [2,9], nateglinide [8], glibenclamide [7], penicillin G (benzylpenicillin) [6], polymyxins (i.e. polymyxin B and colistin) [4] and entecavir [10]. PEPT2 has been shown to interact with dipeptides of p-borono-L-phenylalanine (BPA) and tyrosine (i.e. L-Tyr-p-L-BPA (Tyr-BPA), p-L-BPA-L-tyrosine (BPA-Tyr)) [5] and with AuIII‐peptidodithiocarbamato complexes of the type [AuIIIBr2(dtc‐AA1‐AA2‐OR), in which AA1 = N‐methylglycine (Sar), L/D‐Pro; AA2 = L/D‐Ala, α‐aminoisobutyric acid (Aib); R = OtBu, triethylene glycol methyl ether, e.g. dtc‐Pro‐Aib‐OtBu) [1]. |